Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-03-2010 | Letter to the Editor

A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

Authors: Christine Schmucker, Gerd Antes, Monika Lelgemann

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 3/2010

Excerpt

Dear Editor, …

Bashshur ZF, Schakal A, Hamam RN, El Haibi CP, Jaafar RF, Noureddin B (2007) Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration. Arch Ophthalmol 125:1357–1361CrossRefPubMed

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–69CrossRefPubMed

Lazic R, Gabric N (2007) Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:68–73CrossRefPubMed

Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, Vecsei-Marlovits P, Schmidt-Erfurth U (2007) Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macular degenereation. Ophthalmologe 104:588–593CrossRefPubMed

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431CrossRefPubMed

Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ, Pan American Collaborative Retina Group (PACORES) (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246:81–87CrossRefPubMed

Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344–1349CrossRefPubMed

IVAN Study. www.controlled-trials.com. ISRCTN92166560. Accessed July 30, 2009

CATT Study. www.clinicaltrials.gov. NCT00593450. Accessed July 30, 2009

10.

EQUAL Study. http://apps.who.int/trialsearch/. NTR1331. Accessed July 30, 2009

11.

VIBERA Study. www.clinicaltrials.gov. NCT00559715. Accessed July 30, 2009

Title: A systematic review on the effect of bevacizumab in exudative age-related macular degeneration
Authors: Christine Schmucker
Gerd Antes
Monika Lelgemann
Publication date: 01-03-2010
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 3/2010
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-009-1249-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2010

Impaired aortic stiffness and pulse wave velocity in patients with branch retinal vein occlusion

Smokestack leak in central serous chorioretinopathy

Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery

Wartime open globe eye injuries

Evaluation of optic nerve head and retinal nerve fiber layer in early and advance glaucoma using frequency-domain optical coherence tomography

Ocular injuries sustained in paintball trauma